High-Risk CLL: Advances in Treatment
CLL patients with certain genetic markers are considered to be “high risk” and their options for treatment have historically been limited. CLL expert Dr. Jeff Sharman joins Patient Power to discuss em...
Author: P2Professional
Added: 11/12/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Genetics